Brief: Omnicell Q1 Revenue USD 246 Million Vs. IBES Estimate USD 236.8 Million
May 02 (Reuters) - Omnicell Q1 adjusted EBITDA USD 11 million vs. IBES estimate USD 3.64 million. * Q1 adjusted net income USD 1 million vs. IBES estimate USD -4.26 million * Q1 net income USD -16 million * outlook Q2 adjusted EBITDA USD 14-20 million * outlook FY adjusted EBITDA USD 90-120 million
Recent news on Omnicell
See all newsCorrected: U.S. RESEARCH ROUNDUP-Abbvie, Amazon, Illumina
Omnicell Inc reports results for the quarter ended June 30 - Earnings Summary
Omnicell Q2 adjusted EPS beats estimates, but tightens 2026 revenue guidance
Brief: Omnicell Welcomes Hospital Pharmacy Leader Rick Couldry As Senior Vice President
Omnicell Q1 adjusted EPS beats helped by connected devices demand, raises FY outlook